Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Managing PCOS is hard because it varies a lot, treatments are limited, and there's a lot of false information online.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Women with PCOS have lower self-esteem and body image satisfaction.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Polycystic Ovary Syndrome (PCOS) is a complex disorder with both immediate and long-term health effects, including menstrual issues, infertility, and increased risk of diabetes and heart disease.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

Eye drops with β-blockers may cause hair loss.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Multimedia education greatly improves women's knowledge and management of PCOS.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Electrical epilation damages hair follicles and surrounding skin, likely preventing hair regrowth.